Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation

Saved in:
Bibliographic Details
Published in:ImmunoTargets and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553705071050753
collection WordPress RSS
FRELIP Feed Integration
container_title ImmunoTargets and Therapy
description
discipline_display Allergology and Immunology
discipline_facet Allergology and Immunology
format Online Article
RSS Article
genre Journal Article
id rss_article:84510
institution FRELIP
journal_source_facet ImmunoTargets and Therapy
last_indexed 2026-06-20T21:41:14.952Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
Allergology and Immunology
General
Allergology and Immunology
sub_discipline_display General
sub_discipline_facet General
subject_display Allergology and Immunology
General
Allergology and Immunology
subject_facet Allergology and Immunology
General
Allergology and Immunology
title Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_alt La kasugamicina inhibe la metástasis pulmonar del melanoma y la diferenciación de macrófagos asociados a tumores tipo M2 impulsada por CHI3L1
La kasugamycine inhibe la métastase pulmonaire du mélanome et la différenciation des macrophages associés aux tumeurs de type M2 pilotée par CHI3L1
Kasugamicina Inibe Metástase Pulmonar de Melanoma e Diferenciação de Macrófagos Associados a Tumor do Tipo M2 Impulsionada por CHI3L1
title_auth Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_es_txt La kasugamicina inhibe la metástasis pulmonar del melanoma y la diferenciación de macrófagos asociados a tumores tipo M2 impulsada por CHI3L1
title_fr_txt La kasugamycine inhibe la métastase pulmonaire du mélanome et la différenciation des macrophages associés aux tumeurs de type M2 pilotée par CHI3L1
title_full Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_fullStr Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_full_unstemmed Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_pt_txt Kasugamicina Inibe Metástase Pulmonar de Melanoma e Diferenciação de Macrófagos Associados a Tumor do Tipo M2 Impulsionada por CHI3L1
title_short Kasugamycin Inhibits Melanoma Lung Metastasis and CHI3L1-Driven M2-Like Tumor-Associated Macrophage Differentiation
title_sort kasugamycin inhibits melanoma lung metastasis and chi3l1-driven m2-like tumor-associated macrophage differentiation
topic Allergology and Immunology
General
Allergology and Immunology
url https://www.dovepress.com/kasugamycin-inhibits-melanoma-lung-metastasis-and-chi3l1-driven-m2-lik-peer-reviewed-fulltext-article-ITT